ANTICANCER BIOSCIENCES
Anticancer Bioscience (ACB) is an international private company, commercialising discoveries emerging from China’s world-leading cancer research at the J. Michael Bishop Institute of Cancer Research.
ANTICANCER BIOSCIENCES
Industry:
Biotechnology Health Care Life Science Oncology Pharmaceutical Therapeutics
Founded:
2016-01-01
Address:
Chengdu, Sichuan, China
Country:
China
Website Url:
http://www.anticancerbio.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
200.15 M CNY
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Euro Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Analytics Google Maps Global Site Tag Google Analytics 4
Similar Organizations
Avstera Therapeutics
Avstera Therapeutics is an oncology-focused biotech company that fulfil unmet needs of cancer patients.
Enliven Therapeutics
Enliven Therapeutics is a precision oncology company developing small molecule therapies to extend and improve patient lives.
Geneos Therapeutics
Geneos Therapeutics is a developer of a neo-antigen based personalized immunotherapy designed to offer cancer treatment.
Iroko Pharmaceuticals
Iroko Pharmaceuticals is a global specialty pharmaceutical company dedicated to advancing the science of analgesia.
Navrogen
Navrogen is a biopharmaceutical company focused on the targeted treatment of cancer.
Pinpoint Therapeutics
Pinpoint Therapeutics is a preclinical stage company developing novel cancer treatment options aimed to specifically inhibit autophagy.
Scout Bio
Scout Bi is a biotechnology company that provides veterinary, animal health, and gene therapy.
Current Employees Featured
Founder
Investors List
3 Rivers Capital
3 Rivers Capital investment in Seed Round - Anticancer Biosciences
Official Site Inspections
http://www.anticancerbio.com Semrush global rank: 15.82 M Semrush visits lastest month: 1
- Host name: 109.228.52.133
- IP address: 109.228.52.133
- Location: United Kingdom
- Latitude: 51.4964
- Longitude: -0.1224
- Timezone: Europe/London

More informations about "Anticancer Biosciences"
About – Anticancer Bioscience
We have access to world-leading cancer biology expertise and drug discovery platforms that enable us to identify novel compounds that can target both genetic and epigenetic …See details»
Team – Anticancer Bioscience
Anticancer Bioscience is a highly ambitious, emerging, fast-growing and international precision oncology company, led by a management team that has world-class expertise in cancer research, and in innovating genetic tools such …See details»
Anticancer Biosciences - Crunchbase Company Profile …
Organization. Anticancer Biosciences . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. ... Contact Email [email protected]; Anticancer Bioscience (ACB) is an …See details»
Anticancer Bioscience - LinkedIn
Anticancer Bioscience | 667 followers on LinkedIn. Applying our synthetic lethality expertise for better cancer therapies | We are Anticancer Bioscience (ACB), Ltd., a growing precision ...See details»
Anticancer Bioscience - PitchBook
Information on valuation, funding, cap tables, investors, and executives for Anticancer Bioscience. Use the PitchBook Platform to explore the full profile.See details»
Anticancer Bioscience - Craft
Anticancer Bioscience is a precision oncology company that applies synthetic lethal approaches to develop targeted cancer therapies. It aims to advance broad-spectrum targeted therapies …See details»
Anticancer Biosciences | VentureRadar
Website: https://www.anticancerbio.com/ Develops targeted cancer therapies utilizing synthetic lethal approaches, focusing on MYC overexpression to treat aggressive ...See details»
Investors – Anticancer Bioscience
We are ambitious and intend to make rapid progress. Although well financed, we are open to initiating discussions with specialist life science investors, and/or the venture arms of pharma …See details»
Anticancer Bioscience | LinkedIn
Anticancer Bioscience | 663 followers on LinkedIn. Applying our synthetic lethality expertise for better cancer therapies | We are Anticancer Bioscience (ACB), Ltd., a growing precision …See details»
Anticancer Bioscience (ACB) Ltd. (成都安泰康赛生物科技有限公司)
关于成都安泰康赛生物科技公司 安泰康赛生物科技公司 ( www.anticancerbio.com), 作为毕晓普癌症研究所 ( http:\/\/www.mbicr.cn) 的商业化合作伙伴,自2016年成立以来,专注于MYC合成 …See details»
Anticancer Bioscience - LinkedIn
Anticancer Bioscience | 626 followers on LinkedIn. Applying our synthetic lethality expertise for better cancer therapies | We are Anticancer Bioscience (ACB), Ltd., a growing precision …See details»
Anticancer Bioscience’s Dun Yang, PhD Has Been Named as a
Chengdu, China, April 19, 2022 – Anticancer Bioscience (ACB), pioneers in synthetic lethal approaches to precision oncology, is delighted to announce that their Founder, President and …See details»
Anticancer Bioscience Announces its First Granted US Patent for ...
Sep 9, 2021 Anticancer Bioscience (ACB), pioneers in synthetic lethal approaches to precision oncology, announced today its first granted US patent (11104633), entitled “cancer treatment …See details»
Anticancer Biosciences - VentureRadar
May 5, 2021 Similar Companies: Ideaya Biosciences, Inc. USA Privately Held IDEAYA is an oncology-focused biotechnology company committed to the discovery of breakthrough …See details»
Our Heritage – Anticancer Bioscience
Inspiration comes from many places. At Anticancer Bioscience our science is inspired by both the cutting edge approach of western drug discovery and medicinal chemistry, alongside …See details»
Anticancer Bioscience Announces CNY63m (~USD10m
Feb 8, 2021 At the company Anticancer Bioscience [email protected] Media relations Scius Communications Sue Charles +44 (0) 7968 726585 [email protected] …See details»
Anticancer Bioscience Welcomes New Investor into Seed …
Oct 14, 2021 At the company Anticancer Bioscience [email protected] Media relations Scius Communications Sue Charles +44 (0) 7968 726585 [email protected] …See details»
Anticancer Bioscience Announces Preclinical Data of Lead …
May 11, 2021 At the company Anticancer Bioscience [email protected] Media relations Scius Communications Sue Charles +44 (0) 7968 726585 [email protected]. …See details»
Science – Anticancer Bioscience
Synthetic lethality arises when a combination of two anomalies leads to cell death, whereas either anomaly alone does not. The anomalies can arise through genomic copy number changes, …See details»